Global Antidiabetic Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 25-Jun-2018
No. of pages: 134

Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and ß cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug

Scope of the Report:

This report focuses on the Antidiabetic Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.

Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas.

The worldwide market for Antidiabetic Drug is expected to grow at a CAGR of roughly 9.0% over the next five years, will reach 76300 million US$ in 2023, from 49600 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Sanofi-Aventis

- Eli Lilly

- Oramed

- Takeda

- Boehringer Ingelheim

- Novo Nordisk

- Halozyme Therapeutics

- Bristol-Myers Squibb

- Pfizer

- Tonghua Dongbao

- Biocon

- Wockhardt

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Alpha-Glucosidase Inhibitors

- Biguanides, Sulphonylureas

- Glp-1 Agonist

- Meglitinides

- Dpp-4 Inhibitors

- Sglt-2

- Thiazolodinediones

Market Segment by Applications, can be divided into

- Type I Diabetes

- Type II Diabetes

There are 15 Chapters to deeply display the global Antidiabetic Drug market.

Chapter 1, to describe Antidiabetic Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Antidiabetic Drug, with sales, revenue, and price of Antidiabetic Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Antidiabetic Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Antidiabetic Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Antidiabetic Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Antidiabetic Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Antidiabetic Drug Introduction
1.2 Market Analysis by Type
1.2.1 Alpha-Glucosidase Inhibitors
1.2.2 Biguanides, Sulphonylureas
1.2.3 Glp-1 Agonist
1.2.4 Meglitinides
1.2.5 Dpp-4 Inhibitors
1.2.6 Sglt-2
1.2.7 Thiazolodinediones
1.3 Market Analysis by Applications
1.3.1 Type I Diabetes
1.3.2 Type II Diabetes
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi-Aventis
2.1.1 Business Overview
2.1.2 Antidiabetic Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi-Aventis Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Antidiabetic Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Oramed
2.3.1 Business Overview
2.3.2 Antidiabetic Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Oramed Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Takeda
2.4.1 Business Overview
2.4.2 Antidiabetic Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Takeda Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Antidiabetic Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novo Nordisk
2.6.1 Business Overview
2.6.2 Antidiabetic Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novo Nordisk Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Halozyme Therapeutics
2.7.1 Business Overview
2.7.2 Antidiabetic Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Halozyme Therapeutics Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bristol-Myers Squibb
2.8.1 Business Overview
2.8.2 Antidiabetic Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bristol-Myers Squibb Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Antidiabetic Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Tonghua Dongbao
2.10.1 Business Overview
2.10.2 Antidiabetic Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tonghua Dongbao Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Biocon
2.11.1 Business Overview
2.11.2 Antidiabetic Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Biocon Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Wockhardt
2.12.1 Business Overview
2.12.2 Antidiabetic Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Wockhardt Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Antidiabetic Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Antidiabetic Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antidiabetic Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Antidiabetic Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Antidiabetic Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Antidiabetic Drug Market Analysis by Regions
4.1 Global Antidiabetic Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Antidiabetic Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Antidiabetic Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Antidiabetic Drug Sales and Growth Rate (2013-2018)
4.3 Europe Antidiabetic Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antidiabetic Drug Sales and Growth Rate (2013-2018)
4.5 South America Antidiabetic Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antidiabetic Drug Sales and Growth Rate (2013-2018)
5 North America Antidiabetic Drug by Countries
5.1 North America Antidiabetic Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Antidiabetic Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Antidiabetic Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Antidiabetic Drug Sales and Growth Rate (2013-2018)
5.3 Canada Antidiabetic Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Antidiabetic Drug Sales and Growth Rate (2013-2018)
6 Europe Antidiabetic Drug by Countries
6.1 Europe Antidiabetic Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Antidiabetic Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Antidiabetic Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antidiabetic Drug Sales and Growth Rate (2013-2018)
6.3 UK Antidiabetic Drug Sales and Growth Rate (2013-2018)
6.4 France Antidiabetic Drug Sales and Growth Rate (2013-2018)
6.5 Russia Antidiabetic Drug Sales and Growth Rate (2013-2018)
6.6 Italy Antidiabetic Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Antidiabetic Drug by Countries
7.1 Asia-Pacific Antidiabetic Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Antidiabetic Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Antidiabetic Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Antidiabetic Drug Sales and Growth Rate (2013-2018)
7.3 Japan Antidiabetic Drug Sales and Growth Rate (2013-2018)
7.4 Korea Antidiabetic Drug Sales and Growth Rate (2013-2018)
7.5 India Antidiabetic Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antidiabetic Drug Sales and Growth Rate (2013-2018)
8 South America Antidiabetic Drug by Countries
8.1 South America Antidiabetic Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Antidiabetic Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Antidiabetic Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antidiabetic Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Antidiabetic Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Antidiabetic Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Antidiabetic Drug by Countries
9.1 Middle East and Africa Antidiabetic Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antidiabetic Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Antidiabetic Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antidiabetic Drug Sales and Growth Rate (2013-2018)
9.3 UAE Antidiabetic Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Antidiabetic Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Antidiabetic Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Antidiabetic Drug Sales and Growth Rate (2013-2018)
10 Global Antidiabetic Drug Market Segment by Type
10.1 Global Antidiabetic Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Antidiabetic Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Antidiabetic Drug Revenue and Market Share by Type (2013-2018)
10.2 Alpha-Glucosidase Inhibitors Sales Growth and Price
10.2.1 Global Alpha-Glucosidase Inhibitors Sales Growth (2013-2018)
10.2.2 Global Alpha-Glucosidase Inhibitors Price (2013-2018)
10.3 Biguanides, Sulphonylureas Sales Growth and Price
10.3.1 Global Biguanides, Sulphonylureas Sales Growth (2013-2018)
10.3.2 Global Biguanides, Sulphonylureas Price (2013-2018)
10.4 Glp-1 Agonist Sales Growth and Price
10.4.1 Global Glp-1 Agonist Sales Growth (2013-2018)
10.4.2 Global Glp-1 Agonist Price (2013-2018)
10.5 Meglitinides Sales Growth and Price
10.5.1 Global Meglitinides Sales Growth (2013-2018)
10.5.2 Global Meglitinides Price (2013-2018)
10.6 Dpp-4 Inhibitors Sales Growth and Price
10.6.1 Global Dpp-4 Inhibitors Sales Growth (2013-2018)
10.6.2 Global Dpp-4 Inhibitors Price (2013-2018)
10.7 Sglt-2 Sales Growth and Price
10.7.1 Global Sglt-2 Sales Growth (2013-2018)
10.7.2 Global Sglt-2 Price (2013-2018)
10.8 Thiazolodinediones Sales Growth and Price
10.8.1 Global Thiazolodinediones Sales Growth (2013-2018)
10.8.2 Global Thiazolodinediones Price (2013-2018)
11 Global Antidiabetic Drug Market Segment by Application
11.1 Global Antidiabetic Drug Sales Market Share by Application (2013-2018)
11.2 Type I Diabetes Sales Growth (2013-2018)
11.3 Type II Diabetes Sales Growth (2013-2018)
12 Antidiabetic Drug Market Forecast (2018-2023)
12.1 Global Antidiabetic Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Antidiabetic Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Antidiabetic Drug Market Forecast (2018-2023)
12.2.2 Europe Antidiabetic Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Antidiabetic Drug Market Forecast (2018-2023)
12.2.4 South America Antidiabetic Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Antidiabetic Drug Market Forecast (2018-2023)
12.3 Antidiabetic Drug Market Forecast by Type (2018-2023)
12.3.1 Global Antidiabetic Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Antidiabetic Drug Market Share Forecast by Type (2018-2023)
12.4 Antidiabetic Drug Market Forecast by Application (2018-2023)
12.4.1 Global Antidiabetic Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Antidiabetic Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Antidiabetic Drug Picture
Table Product Specifications of Antidiabetic Drug
Figure Global Sales Market Share of Antidiabetic Drug by Types in 2017
Table Antidiabetic Drug Types for Major Manufacturers
Figure Alpha-Glucosidase Inhibitors Picture
Figure Biguanides, Sulphonylureas Picture
Figure Glp-1 Agonist Picture
Figure Meglitinides Picture
Figure Dpp-4 Inhibitors Picture
Figure Sglt-2 Picture
Figure Thiazolodinediones Picture
Figure Antidiabetic Drug Sales Market Share by Applications in 2017
Figure Type I Diabetes Picture
Figure Type II Diabetes Picture
Figure United States Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Antidiabetic Drug Revenue (Value) and Growth Rate (2013-2023)
Table Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table Sanofi-Aventis Antidiabetic Drug Type and Applications
Table Sanofi-Aventis Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Antidiabetic Drug Type and Applications
Table Eli Lilly Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Oramed Basic Information, Manufacturing Base and Competitors
Table Oramed Antidiabetic Drug Type and Applications
Table Oramed Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Antidiabetic Drug Type and Applications
Table Takeda Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Antidiabetic Drug Type and Applications
Table Boehringer Ingelheim Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Antidiabetic Drug Type and Applications
Table Novo Nordisk Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Halozyme Therapeutics Basic Information, Manufacturing Base and Competitors
Table Halozyme Therapeutics Antidiabetic Drug Type and Applications
Table Halozyme Therapeutics Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Antidiabetic Drug Type and Applications
Table Bristol-Myers Squibb Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Antidiabetic Drug Type and Applications
Table Pfizer Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table Tonghua Dongbao Antidiabetic Drug Type and Applications
Table Tonghua Dongbao Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Antidiabetic Drug Type and Applications
Table Biocon Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Wockhardt Basic Information, Manufacturing Base and Competitors
Table Wockhardt Antidiabetic Drug Type and Applications
Table Wockhardt Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Antidiabetic Drug Sales by Manufacturer (2016-2017)
Figure Global Antidiabetic Drug Sales Market Share by Manufacturer in 2016
Figure Global Antidiabetic Drug Sales Market Share by Manufacturer in 2017
Table Global Antidiabetic Drug Revenue by Manufacturer (2016-2017)
Figure Global Antidiabetic Drug Revenue Market Share by Manufacturer in 2016
Figure Global Antidiabetic Drug Revenue Market Share by Manufacturer in 2017
Figure Top 3 Antidiabetic Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Antidiabetic Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Global Antidiabetic Drug Revenue and Growth Rate (2013-2018)
Table Global Antidiabetic Drug Sales by Regions (2013-2018)
Table Global Antidiabetic Drug Sales Market Share by Regions (2013-2018)
Table Global Antidiabetic Drug Revenue by Regions (2013-2018)
Figure Global Antidiabetic Drug Revenue Market Share by Regions in 2013
Figure Global Antidiabetic Drug Revenue Market Share by Regions in 2017
Figure North America Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Europe Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure South America Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure North America Antidiabetic Drug Revenue and Growth Rate (2013-2018)
Table North America Antidiabetic Drug Sales by Countries (2013-2018)
Table North America Antidiabetic Drug Sales Market Share by Countries (2013-2018)
Figure North America Antidiabetic Drug Sales Market Share by Countries in 2013
Figure North America Antidiabetic Drug Sales Market Share by Countries in 2017
Table North America Antidiabetic Drug Revenue by Countries (2013-2018)
Table North America Antidiabetic Drug Revenue Market Share by Countries (2013-2018)
Figure North America Antidiabetic Drug Revenue Market Share by Countries in 2013
Figure North America Antidiabetic Drug Revenue Market Share by Countries in 2017
Figure United States Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Canada Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Mexico Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Europe Antidiabetic Drug Revenue and Growth Rate (2013-2018)
Table Europe Antidiabetic Drug Sales by Countries (2013-2018)
Table Europe Antidiabetic Drug Sales Market Share by Countries (2013-2018)
Table Europe Antidiabetic Drug Revenue by Countries (2013-2018)
Figure Europe Antidiabetic Drug Revenue Market Share by Countries in 2016
Figure Europe Antidiabetic Drug Revenue Market Share by Countries in 2017
Figure Germany Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure UK Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure France Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Russia Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Italy Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Antidiabetic Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Antidiabetic Drug Sales by Countries (2013-2018)
Table Asia-Pacific Antidiabetic Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Antidiabetic Drug Sales Market Share by Countries 2017
Table Asia-Pacific Antidiabetic Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Antidiabetic Drug Revenue Market Share by Countries 2017
Figure China Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Japan Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Korea Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure India Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure South America Antidiabetic Drug Revenue and Growth Rate (2013-2018)
Table South America Antidiabetic Drug Sales by Countries (2013-2018)
Table South America Antidiabetic Drug Sales Market Share by Countries (2013-2018)
Figure South America Antidiabetic Drug Sales Market Share by Countries in 2017
Table South America Antidiabetic Drug Revenue by Countries (2013-2018)
Table South America Antidiabetic Drug Revenue Market Share by Countries (2013-2018)
Figure South America Antidiabetic Drug Revenue Market Share by Countries in 2017
Figure Brazil Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Argentina Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Colombia Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Antidiabetic Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Antidiabetic Drug Sales by Countries (2013-2018)
Table Middle East and Africa Antidiabetic Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Antidiabetic Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Antidiabetic Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Antidiabetic Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Antidiabetic Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Antidiabetic Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure UAE Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Egypt Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Antidiabetic Drug Sales and Growth Rate (2013-2018)
Figure South Africa Antidiabetic Drug Sales and Growth Rate (2013-2018)
Table Global Antidiabetic Drug Sales by Type (2013-2018)
Table Global Antidiabetic Drug Sales Share by Type (2013-2018)
Table Global Antidiabetic Drug Revenue by Type (2013-2018)
Table Global Antidiabetic Drug Revenue Share by Type (2013-2018)
Figure Global Alpha-Glucosidase Inhibitors Sales Growth (2013-2018)
Figure Global Alpha-Glucosidase Inhibitors Price (2013-2018)
Figure Global Biguanides, Sulphonylureas Sales Growth (2013-2018)
Figure Global Biguanides, Sulphonylureas Price (2013-2018)
Figure Global Glp-1 Agonist Sales Growth (2013-2018)
Figure Global Glp-1 Agonist Price (2013-2018)
Figure Global Meglitinides Sales Growth (2013-2018)
Figure Global Meglitinides Price (2013-2018)
Figure Global Dpp-4 Inhibitors Sales Growth (2013-2018)
Figure Global Dpp-4 Inhibitors Price (2013-2018)
Figure Global Sglt-2 Sales Growth (2013-2018)
Figure Global Sglt-2 Price (2013-2018)
Figure Global Thiazolodinediones Sales Growth (2013-2018)
Figure Global Thiazolodinediones Price (2013-2018)
Table Global Antidiabetic Drug Sales by Application (2013-2018)
Table Global Antidiabetic Drug Sales Share by Application (2013-2018)
Figure Global Type II Diabetes Sales Growth (2013-2018)
Figure Global Antidiabetic Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Antidiabetic Drug Sales Forecast by Regions (2018-2023)
Table Global Antidiabetic Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Antidiabetic Drug Market Forecast (2018-2023)
Figure Europe Sales Antidiabetic Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Antidiabetic Drug Market Forecast (2018-2023)
Figure South America Sales Antidiabetic Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Antidiabetic Drug Market Forecast (2018-2023)
Table Global Antidiabetic Drug Sales Forecast by Type (2018-2023)
Table Global Antidiabetic Drug Market Share Forecast by Type (2018-2023)
Table Global Antidiabetic Drug Sales Forecast by Application (2018-2023)
Table Global Antidiabetic Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Investigation Report on Chinese Epoetin Alfa Market, 2018-2022
    Published: 13-Jul-2018        Price: US 2200 Onwards        Pages: 30
    Description Epoetin Alfa refers to erythropoietin (EPO). EPO in the human body is a hormone-like substance secreted by the kidneys and liver to promote erythropoiesis. The indications for EPO approved in China are renal anemia, chemotherapy-induced anemia, and perioperative erythrocyte mobilization. In Jun. 1989, FDA-approved Epoetin Alfa was launched in the U.S. in the trade name of "Epogen". It is sold in over 40 countries nowadays. The report in ......
  • Investigation Report on Chinese Pregabalin Market, 2018-2022
    Published: 13-Jul-2018        Price: US 2200 Onwards        Pages: 30
    Description Pregabalin is a new-generation drug for neuralgia treatment. In Jul. 2004, it was approved by the European Union to treat some epileptic seizures in adults. In Dec. 2004, it was approved by the U.S. Food and Drug Administration (FDA) to treat diabetic peripheral neuralgia and postherpetic neuralgia. In 2006, generalized anxiety disorder and social anxiety disorder became new indications of Pregabalin. In 2007, Pregabalin was approved by the FDA as the first drug to tre......
  • 2018-2023 Global Intravesical Bacillus Calmette Consumption Market Report
    Published: 12-Jul-2018        Price: US 4660 Onwards        Pages: 135
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Intravesical Bacillus Calmette market for 2018-2023. Intravesical Bacillus Calmette is used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.......
  • 2018 Top 5 Intravesical Bacillus Calmette Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 12-Jul-2018        Price: US 4960 Onwards        Pages: 124
    Intravesical Bacillus Calmette is used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive. In the last several years, Global market of Intravesical Bacillus Calmette developed rapidly, with an average growth rate of 5.32%. In 2016, Global revenue of Intravesical Bacillus Calmette ......
  • 2018-2023 Global Pharmaceutical Intermediates Consumption Market Report
    Published: 12-Jul-2018        Price: US 4660 Onwards        Pages: 167
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Pharmaceutical Intermediates market for 2018-2023. Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates,......
  • 2018 Top 5 Pharmaceutical Intermediates Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 12-Jul-2018        Price: US 4960 Onwards        Pages: 144
    Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc. This industry is affected by the economy and policy, so it's important......
  • Global and United States Recombinant Peptides Market Research by Company, Type & Application 2013-2025
    Published: 12-Jul-2018        Price: US 2000 Onwards        Pages: 117
    Summary Market Segment as follows: By Type Glucagon Calcitonin Others By Application Oncology Blood Disorders Infectious Diseases Autoimmune Diseases Others By Company Sandoz Pharma Stada Arzneimittel Amgen Hospira Actavis Cipla Ltd. Wockhardt Ltd. Biocon Ltd. The main contents of the report including: ......
  • 2018-2023 Global Mildronate Dihydrate Consumption Market Report
    Published: 12-Jul-2018        Price: US 4660 Onwards        Pages: 136
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Mildronate Dihydrate market for 2018-2023. Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic' drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart condition......
  • 2018 Top 5 Mildronate Dihydrate Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 12-Jul-2018        Price: US 4960 Onwards        Pages: 124
    Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic' drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body's ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs